Drugs / zotarolimus
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03647475 | Oct 2018 → Mar 2020 | coronary artery disorder | Medtronic Vascular | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | zotarolimus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03647475 ↗ |
| Known as | ABT-578 | ChEMBL registry synonym — accepted as the source's own label CHEMBL219410 ↗ |
| Known as | Mdt-4107 | ChEMBL registry synonym — accepted as the source's own label CHEMBL219410 ↗ |
| Action | Inhibit | “FK506-binding protein 1A inhibitor” CHEMBL219410 ↗ |
| Modality | Small molecule | — CHEMBL219410 ↗ |
| Target | FKBP1A | “FK506-binding protein 1A inhibitor” CHEMBL219410 ↗ |